Terms: = Lung cancer AND NIN, KIAA1565, 51199, ENSG00000100503
13 results:
1. Genomic and transcriptomic profiling reveals key molecules in metastatic potentials and organ-tropisms of hepatocellular carcinoma.
Shi DM; Dong SS; Zhou HX; Song DQ; Wan JL; Wu WZ
Cell Signal; 2023 Apr; 104():110565. PubMed ID: 36539000
[TBL] [Abstract] [Full Text] [Related]
2. Ni(II) curcumin complexes for cellular imaging and photo-triggered in vitro anticancer activity.
Banaspati A; Raza MK; Goswami TK
Eur J Med Chem; 2020 Oct; 204():112632. PubMed ID: 32781350
[TBL] [Abstract] [Full Text] [Related]
3. miR‑145 inhibits human non‑small-cell lung cancer growth by dual-targeting RIOK2 and NOB1.
Liu K; Chen H; You Q; Ye Q; Wang F; Wang S; Zhang S; Yu K; Li W; Gu M
Int J Oncol; 2018 Jul; 53(1):257-265. PubMed ID: 29749434
[TBL] [Abstract] [Full Text] [Related]
4. Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.
Kong R; Liu W; Guo Y; Feng J; Cheng C; Zhang X; Ma Y; Li S; Jiang J; Zhang J; Qiao Z; Qin J; Lu T; He X
Oncol Rep; 2017 Oct; 38(4):2572-2580. PubMed ID: 28849232
[TBL] [Abstract] [Full Text] [Related]
5. Nickel Release, ROS Generation and Toxicity of Ni and NiO Micro- and Nanoparticles.
Latvala S; Hedberg J; Di Bucchianico S; Möller L; Odnevall Wallinder I; Elihn K; Karlsson HL
PLoS One; 2016; 11(7):e0159684. PubMed ID: 27434640
[TBL] [Abstract] [Full Text] [Related]
6. Acquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expression.
Englinger B; Lötsch D; Pirker C; Mohr T; van Schoonhoven S; Boidol B; Lardeau CH; Spitzwieser M; Szabó P; Heffeter P; Lang I; Cichna-Markl M; Grasl-Kraupp B; Marian B; Grusch M; Kubicek S; Szakács G; Berger W
Oncotarget; 2016 Aug; 7(31):50161-50179. PubMed ID: 27367030
[TBL] [Abstract] [Full Text] [Related]
7. High Expression of RIOK2 and NOB1 Predict Human Non-small Cell lung cancer Outcomes.
Liu K; Chen HL; Wang S; Gu MM; Chen XM; Zhang SL; Yu KJ; You QS
Sci Rep; 2016 Jun; 6():28666. PubMed ID: 27346559
[TBL] [Abstract] [Full Text] [Related]
8. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.
Liu K; Chen HL; Gu MM; You QS
Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885
[TBL] [Abstract] [Full Text] [Related]
9. Lentivirus-mediated gene silencing of NOB1 suppresses non-small cell lung cancer cell proliferation.
Huang W; Zhong W; Xu J; Su B; Huang G; Du J; Liu Q
Oncol Rep; 2015 Sep; 34(3):1510-6. PubMed ID: 26178254
[TBL] [Abstract] [Full Text] [Related]
10. NOB1 expression predicts early response to cisplatin-based chemotherapy in patients with advanced non-small cell lung cancer.
Liu K; Chen HL; Gu MM; You QS
J Chemother; 2016 Jun; 28(3):225-9. PubMed ID: 25971309
[TBL] [Abstract] [Full Text] [Related]
11. Relationship between NOB1 expression and prognosis of resected non-small cell lung cancer.
Liu K; Chen HL; Gu MM; You QS
Int J Biol Markers; 2015 Feb; 30(1):e43-8. PubMed ID: 25450647
[TBL] [Abstract] [Full Text] [Related]
12. Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo.
Li Y; Ma C; Qian M; Wen Z; Jing H; Qian D
Oncol Rep; 2014 Mar; 31(3):1271-6. PubMed ID: 24452698
[TBL] [Abstract] [Full Text] [Related]
13. NOB1 in non-small-cell lung cancer: expression profile and clinical significance.
Liu K; Gu MM; Chen HL; You QS
Pathol Oncol Res; 2014 Apr; 20(2):461-6. PubMed ID: 24272676
[TBL] [Abstract] [Full Text] [Related]
